全球医用氧气市场-2022-2029

市场动态

全球医用氧气市场正在增长，原因包括哮喘、慢性阻塞性肺病和肺癌等呼吸系统疾病的发病率不断上升，这些疾病可能导致严重的健康问题甚至死亡。

预计呼吸系统疾病发病率的上升和技术进步的激增将推动市场的增长。

推动市场增长的主要驱动力是科技进步、呼吸系统疾病发病率增加和新产品推出的增加。

根据世界卫生组织 (WHO) 2022 年报告，2019 年慢性阻塞性肺病 (COPD) 导致约 323 万人死亡，成为全球第三大死因。我来了。大约 90% 的 70 岁以下 COPD 死亡发生在低收入和中等收入国家。医用氧气市场受到呼吸系统疾病日益流行和全球各种新技术改进的推动。各种类型的呼吸系统疾病，如哮喘、肺癌、肺炎和慢性阻塞性肺病，对于可以通过药物治疗控製或预防的疾病和可能致命的疾病，都有不同的危险因素。据说慢性肺病如慢性阻塞性肺病和肺炎在老年人中的患病率很高，因为呼吸肌力量会随着年龄的增长而下降。

吸烟和吸烟等生活方式的改变正在增加慢性阻塞性肺病 (COPD) 和哮喘的患病率。慢性阻塞性肺病 (COPD) 是一种危及生命的进行性慢性肺部疾病，会导致呼吸困难，并且容易恶化和出现严重疾病。根据世界卫生组织 (WHO) 的数据，到 2020 年，全球将有约 2.51 亿人受到慢性阻塞性肺病 (COPD) 的影响。肥胖和烟草消费的增加是全球哮喘、慢性阻塞性肺病和 OSA 患病率上升的主要原因，这将推动全球医用氧气市场。日益严重的环境污染导致慢性阻塞性肺病和哮喘等呼吸系统疾病的发病率急剧上升，增加了对氧疗的需求。

通过此类合作、合併或主要参与者在市场上发布新产品，已经取得了各种新颖的进展。例如，强生视力保健公司于 2021 年开发的名为 Acuvue Oasis 的医用氧气已获得 FDA 批准，可提供舒适性，具有高含水量，并保持清晰的视力和眼睛健康。

与这些医用氧气系统相关的高成本预计将阻碍市场增长。

这些医用氧气系统的高成本及其维护也使其非常昂贵。在 2019 年一篇题为“氧气设备和输送系统”的文章中指出，“以设定的频率重新填充液氧安置系统会产生高昂的服务成本，具体取决于氧气流量设置和单位尺寸。有。”

COVID-19 影响分析

COVID-19 已影响到各个行业，但它是医用氧气市场增长的主要因素。

许多 COVID-19 病例病情严重，需要医用氧气进行治疗。因此，全球对呼吸机、氧气瓶、壁挂式製氧机和罐装氧气的需求猛增，不仅在医院，而且在家庭护理中。医用氧气系统的需求受到 COVID-19 爆发的影响，需求增加导致全球医用呼吸机短缺。出于这个原因，科学家和生物医学工程师正在开发替代设备，这些设备使用现有的设备（例如氧气浓缩器和手动復苏器）模仿呼吸机的常见功能。在美国，随着 FDA 根据紧急使用授权计划授权使用制氧机，预测期内对医用氧气设备的需求正在增加。

本报告提供大约 45 多个市场数据表、40 多个图表和 180 页信息。

内容

第一章研究方法与范围

• 调查方法
• 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

• 市场影响因子
  • 驱动程序
    • 呼吸系统疾病激增和家庭护理产品的演变
  • 约束因素
    • 医用氧气设备成本高
  • 市场机会
  • 影响分析

第五章行业分析

• 波特五力
• 监管分析
• 供应链分析
• 定价分析

第 6 章 COVID-19 分析

• COVID-19 的市场分析
  • COVID-19 之前的市场情景
  • COVID-19 的当前市场情景
  • COVID-19 后或未来情景
• COVID-19 期间的价格动态
• 供需范围
• 大流行期间与市场相关的政府举措
• 製造商的战略举措
• 总结

第 7 章按产品类型

• 氧气浓缩器
• 压缩氧气瓶
• 液氧系统
• 呼吸机
• HFNC

第8章供氧系统

• 低流量系统
• 高流量系统

第 9 章不同模式的氧浓度

• 门静脉供氧
• 固定式氧气

第 10 章按应用程序

• 肺部疾病
• 哮喘
• 心力衰竭
• 囊性纤维化
• 支气管肺疾病
• 其他

第 11 章，最终用户

• 医院
• 紧急医疗中心
• 门诊中心
• 社区关怀
• 高压治疗室
• 居家护理
• 其他

第 12 章按地区划分

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 其他欧洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 其他亚太地区
• 中东和非洲

第 13 章竞争格局

• 主要发展和战略
• 公司份额分析
• 产品基准
• 值得关注的重点公司列表

第 14 章公司简介

• Inogen Incorporation
  • 公司概况
  • 产品组合和描述
  • 主要亮点
  • 财务摘要
• Precision Medical, Inc.
• ResMed Inc.
• Besco Medical Co. Ltd.
• Koninklijke Philips N.V
• Luxfer Group
• Invacare Corporation
• O2 Concepts LLC.
• Responsive Respiratory
• GCE Group

第 15 章全球医用氧气市场-DataM

Market Overview

Medical Oxygen Market size was valued US$ 2,893.53 million in 2021 and is estimated to reach US$ 5,516.82 million by 2029, growing at a CAGR of 7.47% during the forecast period (2022-2029).

Oxygen is used as a life-saving gas that plays crucial role in treatment of patients during surgery, heart failure or trauma. It is a very complex compound and its production takes place in industrial plants. Medical oxygen is the use of oxygen for medical treatment. Oxygen is taken from the air that is purified and compressed to treat patients with respiratory disorders.

Market Dynamics

The global medical oxygen market growth is driven by various factors such as rising incidences of respiratory disorders like asthma, COPD, lung cancer that may lead to severe health issues or can even result in death.

Increasing incidence of respiratory disorders and surge in technological advances are expected to drive the growth of market.

The major drivers helping in the growth of the market are the rise in the scientific and technological advances, increasing incidence of respiratory disease and increasing the novel product launch.

According to World Health Organisation report 2022, chronic obstructive pulmonary disease (COPD) in 2019 caused around 3.23 million deaths and became third main cause for global deaths. Approximately 90% of COPD deaths under 70 years of age takes place in countries with low or middle income. The medical oxygen market is being driven by the increasing prevalence of respiratory disorders and various novel technological improvements across the globe. Different types of respiratory disorders such as asthma, lung cancer, pneumonia, COPD and others have different risk factors where some can be controlled or prevented through drug therapies and others may lead to death. The prevalence of chronic lung disorders such as COPD and pneumonia is high among the older population as respiratory muscle strength decreases as age progresses.

The rising prevalence of chronic obstructive pulmonary disease (COPD) and Asthma owing to the changing lifestyle, including smoking, tobacco consumption, and others. Chronic obstructive pulmonary disease (COPD) is a progressive, chronic life-threatening lung disease that causes breathlessness and predisposes to exacerbations and serious illness. According to the World Health Organization (WHO) in 2020, around 251 million people suffer from Chronic obstructive pulmonary disease (COPD) worldwide. Obesity and increased tobacco consumption are mainly contributing to the rise in the prevalence of asthma, COPD, and OSA globally, which will fuel the global medical oxygen market. The rising environmental pollution has caused a spike in the incidence of COPD, asthma, and other respiratory diseases, leading to an increased demand for oxygen therapy.

Various novel advancements are being done by key players such collaborations, mergers or releasing new products in market. For instance, in 2021 Medical Oxygen known as Acuvue Oasys developed by Johnson and Johnson Vision Care got approved by FDA that provides comfort, have high moisture content, clear vision and maintains good health of eye.

High cost associated with these medical oxygen systems is expected to hamper the market growth.

The high cost of these medical oxygen systems and their maintenance also makes it quite expensive. In 2019 an article titled "Oxygen devices and delivery systems" stated that "There is a high service cost associated with refilling the liquid oxygen stationary systems at a set frequency, contingent on the oxygen flow setting and the unit's size".

COVID-19 Impact Analysis

COVID-19 affected all the fields but it's the main factor for growth in the market of medical oxygen

as majority of COVID-19 cases were severe and needed medical oxygen for treatment. Due to this artificial ventilation, oxygen cylinders, wall-mounted oxygen concentrators and canned oxygen demand increased suddenly in hospitals as well in home care globally. Demand of the medical oxygen systems has been impacted by COVID-19 pandemic, as demand increased and this led to the scarcity of medical ventilators worldwide. To control this, scientists and biomedical engineers have developed substitute devices that will mimic the general functions of ventilators using devices that are already available such as oxygen concentrators and manual resuscitators. In U.S., the FDA permitted using the oxygen concentrators under a program Emergency Use Authorization hence enhancing the demand of the medical oxygen devices in forecast period.

Segment Analysis

Oxygen concentrator segment is expected to hold the largest market share in global medical oxygen market

Oxygen Concentrators segment is expected to hold the largest market share in global medical oxygen market as it's the most used product worldwide. It is efficient to use hence people tend to use it and hence rise in demand. Oxygen concentrators provides oxygen-enriched air that is safe. Oxygen concentrators are devices that takes up the room air that passes through a series of filters which remove dust, bacteria and other particulates. It is a two steps concentration process where in the first step the machine forces air in one cylinder that contains semi-permeable membranes, nitrogen gets absorbed here, that leaves concentrated oxygen (90% or higher) and small amounts of other gases. At the exact time, in the second cylinder, nitrogen gets desorbed and drawn out. In second step, the task of cylinders is reversed in a timed cycle, that provides a continuous flow of oxygen to patient. General oxygen concentrator delivers the oxygen flows of around 0.5-5 L*min-1 (low-flow oxygen concentrators), but some other models can achieve up to 10 L*min-1 (high-flow oxygen concentrators). Such kind of devices are easy to carry and use.

According to an article titled "Oxygen devices and delivery systems" the portable oxygen concentrators are the latest technology for long term oxygen therapy users who desire a small, lightweight and portable oxygen solution in a compact and mobile unit. These concentrators use electrical power hence supply oxygen in unlimited amount and are more cost effective as only need charging.

There is an increase in the number of companies developing the medical oxygen systems such as Inogen Inc., Medtronic, Airgas Inc., Koninklijke Philips, Linde group, Sol groups etc are the major players that are manufacturing novel Medical Oxygen. For instance, in Apr 2020, Linde announced its novel contract with the Indian Oil Corporation Limited, India's biggest refiner that has strengthened its portfolio of extensive technology.

Geographical Analysis

North America region holds the largest market share in the global medical oxygen market

The North America region is expected to lead the market in the upcoming future. Factors such as pervasiveness of respiratory disorders such as asthma, pneumonia, lung cancer, COPD and novel developments in technology are likely to increase the market growth. Currently almost 25 million people have asthma in the United States. COPD have been diagnosed in around 14.8 million adults. Annual expenditures on health care for asthma are estimated around $20.7 billion. In U.S., the FDA permitted using the oxygen concentrators under a program Emergency Use Authorization hence enhancing the demand of the medical oxygen devices.

Major key players are developing novel scientific and advanced technologies to meet the needs of users and provide them with efficient products. For instance, in April 2019, FDA approved Supersaturated oxygen therapy introduced by TherOx that is used to treat the damaged heart tissue safely. Some of the key players are developing mobile apps for convenience of users. due to which this region holds the largest market share in global medical oxygen market.

In Feb 2021, SOL Group, manufacturer of pure medical and technical gases announced that it has acquired Air Liquide Hellas, medical gases and technical gases company operative in Greek market.

Competitive Landscape

The global orthokeratology market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Some of the major key players in the global medical oxygen market are Inogen Incorporation, Precision Medical, Inc., ResMed Inc., Besco Medical Co. Ltd., Koninklijke Philips N.V, Luxfer Group, Invacare Corporation, O2 Concepts LLC., Responsive Respiratory, GCE Group. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in 2021, UNICEF collaborated with The Oxygen CoLab and NEST360 to drive the production of flexible oxygen concentrator for less resource surroundings.

The key companies are focusing on key strategies such as collaboration, acquisitions, and product launches which are boosting the growth of the market globally. For instance,

• In Sep 2022, Responsive Respiratory, a manufacturer of high-pressure oxygen products announced its partnership agreement with Boost Oxygen, provider of products related to respiratory support. With this agreement RRI will distribute Boost Oxygen products.
• In Apr 2021, ResMed, company that develops medical devices related to cloud connect and digital health announced its AirView expansion for the ventilation. It is a cloud-based management platform for patients of respiratory care.
• In Jan 2021, SOL Groups increased its stake in SICGILSOL its Indian joint venture for expanding its availability in Indian market of medical and technical gases.
• In Jun 2020, GCE Healthcare launched Clarity connect care, an online platform for monitoring on its portable oxygen concentrator Zen-O life. Zen-O-life is used for improved management of oxygen therapy of patients with chronic respiratory disease such as COPD in homecare setting.
• In Jun 2020, Medtronic announced its partnership with Foxconn Industrial for production of ventilators. All the regulatory and quality requirements were completed by Foxconn and started Medtronic's ventilator Puritan Bennett 560 manufacturing in United States.

Key Companies to Watch

Inogen Inc.:

Overview: Inogen is a company that deals with medical technologies and manufactures various respiratory products that are generally used in homecare. Their primary products are portable oxygen concentrators that are being used for chronic respiratory conditions suffering patients as it provides long term oxygen therapy. These concentrators are being manufactured and marketed with new advancements in around 57 countries. It was founded in 2001, and is headquartered in California, U.S.

Product Portfolio:

Inogen One G5: It is a portable oxygen concentrator that provides extreme oxygen per pound. It's dense, small and lightly weighted with varying settings of flow for 1-6 that can be used 24 hours.This modal is so efficient and contains easy control functions with LCD displays that is convenient to read. For instance, in 2020 a report tiltled "Oxygen monitoring and control system" stated that "The Inogen One G5 provides 1 LPM continuous at a setting of 6 with 17 breaths minute that is very efficient as compared to others."

Key Developments: In Sep 2021, Inogen, company of medical technology with innovative respiratory products announced its agreement with Ashfield Healthcare to expand its market capabilities.

The global medical oxygen market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The surge in occurrence of the respiratory disorders and new advances in home care product
  • 4.1.2. Restraints:
    • 4.1.2.1. High cost of these medical oxygen devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces
• 5.2. Regulatory Analysis
• 5.3. Supply Chain Analysis
• 5.4. Pricing Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type Segment
• 7.2. Oxygen Concentrator
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Compressed Oxygen Cylinder
• 7.4. Liquid Oxygen Systems
• 7.5. Ventilators
• 7.6. HFNC

8. By System of Oxygen Delivery

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 8.1.2. Market Attractiveness Index, By System of Oxygen Delivery Segment
• 8.2. Low Flow Systems
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. High Flow Systems

9. By Modal Quality

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 9.1.2. Market Attractiveness Index, By Modal Quality Segment
• 9.2. Portal Oxygen
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Stationary Oxygen

10. By Applications

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 10.1.2. Market Attractiveness Index, By Applications Segment
• 10.2. Lung Disorders
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. Asthma
• 10.4. Heart Failure
• 10.5. Cystic Fibrosis
• 10.6. Bronchopulmonary Disorder
• 10.7. Other

11. By End user

• 11.1. Introduction
  • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.1.2. Market Attractiveness Index, By End user Segment
• 11.2. Hospitals
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 11.3. Emergency Medical Centers
• 11.4. Ambulatory Centers
• 11.5. Community Care
• 11.6. Hyperbaric Chambers
• 11.7. Home Care
• 11.8. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.2.8.1. U.S.
    • 12.2.8.2. Canada
    • 12.2.8.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.3.8.1. Germany
    • 12.3.8.2. U.K.
    • 12.3.8.3. France
    • 12.3.8.4. Italy
    • 12.3.8.5. Spain
    • 12.3.8.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.4.8.1. Brazil
    • 12.4.8.2. Argentina
    • 12.4.8.3. Rest of South America
• 12.5. Asia Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.5.8.1. China
    • 12.5.8.2. India
    • 12.5.8.3. Japan
    • 12.5.8.4. Australia
    • 12.5.8.5. Rest of Asia Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.6.4.
  • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.6.7.
  • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.6.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

13. Competitive Landscape

• 13.1. Key Developments and Strategies
• 13.2. Company Share Analysis
• 13.3. Product Benchmarking
• 13.4. List of Key Companies to Watch

14. Company Profiles

• 14.1. Inogen Incorporation
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio and Description
  • 14.1.3. Key Highlights
  • 14.1.4. Financial Overview
• 14.2. Precision Medical, Inc.
• 14.3. ResMed Inc.
• 14.4. Besco Medical Co. Ltd.
• 14.5. Koninklijke Philips N.V
• 14.6. Luxfer Group
• 14.7. Invacare Corporation
• 14.8. O2 Concepts LLC.
• 14.9. Responsive Respiratory
• 14.10. GCE Group

LIST NOT EXHAUSTIVE

15. Global Medical Oxygen Market - DataM

• 15.1 Appendix
• 15.2 About Us
• 15.3 Contact Us